10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...r vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cells to produce the protein of the S-antigen unique to SARS-CoV-2, allowing the body to generate an immune response and to retain that information in memory immune cells. Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
Infection preventions
Hygiene
The COVID-19 pandemic has brought social and economic crisis that is rapidly exacerbating an ongoing nutrition insecurity in Nigeria.
To contain the spread of the pandemic in Nigeria, the government has put in place a number of measures, one of which is the lockdown in the three states of Lagos, ...Ogun, FCT and lately Kano, which have high COVID-19 confirmed cases. Similarly, several other states have adopted measures, such as movement restriction, in order to curb the spread of the pandemic.
more
Community feedback considered in this report was collected through information received from Community Engagement and Accountability (CEA) focal points,as well as through primary data collection,in 10 African countries.Red Cross and Red Crescent National Society CEA focal points were asked to share ...the main rumours, observation, beliefs, questions or suggestions they are hearing in their countries andto grade them according to their frequency. Focal points from the following countries provided information this way: Botswana, Burundi, Cameroon, Niger, South Africa.
more
Ключевые показатели наркопотребления за последние годы почти не изменились, но такая стабиль-ность скрывает серьезные перемены на рынках наркотиков. Помимо давно... существующих нарко-тиков, таких как героин и кокаин, расширяется потребление НПВ, а также употребление в немеди-цинских целях рецептурных препаратов (которые появляются либо в результате утечки с законного рынка, либо производятся незаконно). Также растет потребление веществ неясного происхождения, поставляемых через незаконные каналы. Такие вещества продаются под видом лекарств, но пред-назначаются для немедицинского употребления. Спектр доступных потребителям веществ и их комбинаций сейчас беспрецедентно широк.
more
Key populations brief
Accessed 2017
WHO Factsheet. 14 March 2016